CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Short Term Provisions History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Short Term Provisions | ₹1,793 Cr | ₹1,634 Cr | ₹1,303 Cr | ₹1,242 Cr | ₹1,096 Cr |
What is the latest Short Term Provisions ratio of CIPLA ?
| Year | Short Term Provisions |
|---|---|
| Mar2025 | ₹1,793 Cr |
| Mar2024 | ₹1,634 Cr |
| Mar2023 | ₹1,303 Cr |
| Mar2022 | ₹1,242 Cr |
| Mar2021 | ₹1,096 Cr |
How is Short Term Provisions of CIPLA Trending?
| Years | Short Term Provisions | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,793 Cr | 9.77 | |
| Mar2024 | ₹1,634 Cr | 25.36 | |
| Mar2023 | ₹1,303 Cr | 4.96 | |
| Mar2022 | ₹1,242 Cr | 13.25 | |
| Mar2021 | ₹1,096 Cr | - | |
Compare Short Term Provisions of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹109,032.8 Cr | 1.3% | -7.9% | -6.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹410,442.0 Cr | 0.5% | -1.5% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,878.0 Cr | 5.5% | -0.2% | 0.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹137,301.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,023.0 Cr | 2% | 4.5% | 2.3% | Stock Analytics | |
| MANKIND PHARMA | ₹86,144.2 Cr | 0.2% | -6.3% | -16.6% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 1.3% |
-7.9% |
-6.6% |
| SENSEX | 0.5% |
0.8% |
7.2% |
You may also like the below Video Courses